Capforce Inc (CFOR) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Capforce Inc   (CFOR)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Capforce Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Capforce Inc's ROI in the second quarter of 2026?
Capforce Inc achieved a return on average invested assets (ROI) of 161.42 % in its second quarter of 2026, this is above CFOR's average return on investment of -192.48%.
Capforce Inc invested over the 12 months ending in its second quarter of 2026 $39 million

ROI has improved compared to 102.27% in the first quarter of 2026, due to net income growth.

Within the Healthcare sector 2 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 0 to 45.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 335.32 % 584.77 % - - -
Y / Y Net Income Change TTM 294.86 % 117.05 % 111.78 % 3.4 % -
Investment (TTM) in Millions 76 33 34 12 12
Return On Investment (TTM) 161.42 % 102.27 % 140.91 % 65.08 % 177.96 %
CFOR's Overall Ranking # 45 # 0 # 0 # #
Seq. Investment Change TTM 69.95 % 36.01 % 57.31 % 19.72 % 167.34 %
Seq. Net Income Change TTM 168.24 % -1.29 % 240.63 % -56.22 % 47.45 %
Net Income (TTM) in Millions 62 23 23 7 16

CFOR Company Profile >> Back to CFOR Roi Comparisons >> See Annual CFOR Return On Investment



Return On Investment CFOR's Ranking
Within: No.
Industry # 0
Sector # 3
Overall # 45

Return On Investment Statistics
High Average Low
322.66 %
-192.48 %
-937.4 %
(Mar 31 2025)   (Dec 31 2017)







Financial Statements
Capforce Inc's II. Quarter Investments $ 76 Millions CFOR's Balance sheet
Capforce Inc's II. Quarter Income $ 42 Millions Quarterly CFOR's Income Statement
CFOR's Income by Division See CFOR's Income by Division


CFOR Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 34 9 -10 13 49
Y / Y Investment Growth 263.03 % - - -74.05 % 19.41 %
Net Income in Millions 23 11 -33 -37 -35
Y / Y Net Income Growth 106.75 % - - - -
Annual Return On Investment 70.08 % 123.05 % - -294.61 % -71.37 %


Annual Roi Comment
In the fiscal year 2025 ROI deteriorated to 70.08 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CFOR's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CFOR's Competitors
Subscribers only: Roi for Capforce Inc's Suppliers
Subscribers only: Return On Investment for CFOR's Customers

Other Ratios
CFOR's Roa CFOR's Inventory Turnover Ratio CFOR's Growth Rates CFOR's Dividend Statistics
CFOR's Profitability Ratios CFOR's Asset Turnover Ratio CFOR's Dividend Growth
CFOR's Roe CFOR's Valuation Ratios CFOR's Financial Strength Ratios CFOR's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Omeros Corporation  198.34 %
Elutia Inc   191.75 %
Sanuwave Health Inc   167.92 %
Vor Biopharma Inc   162.71 %
Capforce Inc   161.42 %
Kyntra Bio Inc   157.74 %
Silexion Therapeutics Corp  127.60 %
Quince Therapeutics Inc   112.49 %
Pulmatrix Inc   108.83 %
Interpace Biosciences Inc   100.71 %
Arbutus Biopharma Corp  99.18 %
Rigel Pharmaceuticals Inc  89.00 %
Oncotelic Therapeutics Inc   87.35 %
Actinium Pharmaceuticals Inc  84.38 %
Exelixis Inc   82.05 %
Lensar Inc   75.31 %
Ironwood Pharmaceuticals inc   70.54 %
Oramed Pharmaceuticals Inc  68.90 %
Indivior Pharmaceuticals Inc   68.79 %
Rallybio Corporation  68.28 %
Fortress Biotech Inc   68.27 %
Earth Science Tech Inc   64.38 %
Meiragtx Holdings Plc  55.83 %
Elite Pharmaceuticals Inc   53.48 %
Idexx Laboratories Inc  51.80 %
Aurinia Pharmaceuticals Inc   50.35 %
Qhslab Inc   48.94 %
Q32 Bio Inc   47.43 %
Vaxart Inc   46.17 %
Liquidia Corporation  42.09 %

Date modified: 2026-09-12T06:20:11+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.